ES8801830A1 - Un procedimiento para la preparacion de espiro(imidazolidin-4,4'-(3'h)quinolinas) - Google Patents

Un procedimiento para la preparacion de espiro(imidazolidin-4,4'-(3'h)quinolinas)

Info

Publication number
ES8801830A1
ES8801830A1 ES557391A ES557391A ES8801830A1 ES 8801830 A1 ES8801830 A1 ES 8801830A1 ES 557391 A ES557391 A ES 557391A ES 557391 A ES557391 A ES 557391A ES 8801830 A1 ES8801830 A1 ES 8801830A1
Authority
ES
Spain
Prior art keywords
quinolins
imidazolidin
procedure
reaction
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557391A
Other languages
English (en)
Other versions
ES557391A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES557391A0 publication Critical patent/ES557391A0/es
Publication of ES8801830A1 publication Critical patent/ES8801830A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE ESPIRO(IMIDAZOLIDIN-4,4K-3KH)QUINOLINAS, DE FORMULA (I). COMPRENDE LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN ACIDO HIDRAZOICO, PARA FORMAR UN COMPUESTO DE FORMULA (I), EN LA QUE R REPRESENTA FLUOR, CLORO, HIDROGENO, METILO O METOXI. LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE A LA REACCION, A UNA TEMPERATURA PROXIMA A 20JC. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE CIERTAS COMPLICACIONES CRONICAS DE LA DIABETES MELLITUS.
ES557391A 1985-05-29 1987-02-13 Un procedimiento para la preparacion de espiro(imidazolidin-4,4'-(3'h)quinolinas) Expired ES8801830A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/738,924 US4575507A (en) 1985-05-29 1985-05-29 Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use

Publications (2)

Publication Number Publication Date
ES557391A0 ES557391A0 (es) 1988-02-16
ES8801830A1 true ES8801830A1 (es) 1988-02-16

Family

ID=24970055

Family Applications (2)

Application Number Title Priority Date Filing Date
ES555375A Expired ES8800228A1 (es) 1985-05-29 1986-05-27 Un procedimiento para la preparacion de espiro (imidiazolina-4,1'-(2'h)-naftaleno) y espiro (croman-4,4'-imidazolidinas)
ES557391A Expired ES8801830A1 (es) 1985-05-29 1987-02-13 Un procedimiento para la preparacion de espiro(imidazolidin-4,4'-(3'h)quinolinas)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES555375A Expired ES8800228A1 (es) 1985-05-29 1986-05-27 Un procedimiento para la preparacion de espiro (imidiazolina-4,1'-(2'h)-naftaleno) y espiro (croman-4,4'-imidazolidinas)

Country Status (21)

Country Link
US (1) US4575507A (es)
EP (1) EP0203791B1 (es)
JP (1) JPS61277671A (es)
KR (1) KR890001548B1 (es)
AT (1) ATE46332T1 (es)
AU (1) AU560429B2 (es)
DD (5) DD251972A5 (es)
DE (1) DE3665584D1 (es)
DK (1) DK248886A (es)
EG (1) EG17859A (es)
ES (2) ES8800228A1 (es)
FI (1) FI862251A7 (es)
GR (1) GR861388B (es)
HU (4) HUT49879A (es)
IL (1) IL78954A (es)
NO (1) NO862123L (es)
NZ (1) NZ216334A (es)
PH (1) PH22213A (es)
PL (5) PL146020B1 (es)
PT (1) PT82650B (es)
ZA (1) ZA863934B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000807A1 (en) * 1984-07-20 1986-02-13 Pfizer Inc. Spiro-imidazolones for treatment of diabetes complications
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
WO1988006887A1 (en) * 1987-03-20 1988-09-22 Alcon Laboratories, Inc. Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus
US5202339A (en) * 1987-08-28 1993-04-13 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5004751A (en) * 1987-08-28 1991-04-02 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
FI902028A7 (fi) * 1988-08-24 1990-04-23 Mochida Pharm Co Ltd Hydantoiinijohdannaisia
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US8326636B2 (en) * 2008-01-16 2012-12-04 Canyon Ip Holdings Llc Using a physical phenomenon detector to control operation of a speech recognition engine
WO2013117568A1 (de) * 2012-02-09 2013-08-15 Boehringer Ingelheim International Gmbh Verfahren zur stereoselektiven synthese von 1,4-geschützten 9-hydroxy-5-oxo-1,4-diaza-spiro [5.5] undecane

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117230A (en) 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
DE3367103D1 (en) * 1982-11-10 1986-11-27 Pfizer Sorbinil by optical resolution with aminopinane derivatives
US4556670A (en) 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
SU1380610A3 (ru) * 1982-12-06 1988-03-07 Пфайзер Инк. (Фирма) Способ получени спирогетероазолидиндионов или их фармацевтически приемлемых солей
DE3561198D1 (en) * 1984-03-23 1988-01-28 Pfizer Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4762838A (en) 1985-08-30 1988-08-09 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents

Also Published As

Publication number Publication date
PL147400B1 (en) 1989-05-31
AU560429B2 (en) 1987-04-09
DK248886D0 (da) 1986-05-28
HUT49879A (en) 1989-11-28
NZ216334A (en) 1988-08-30
EP0203791A1 (en) 1986-12-03
DD273258A5 (de) 1989-11-08
ES8800228A1 (es) 1987-11-01
PH22213A (en) 1988-06-28
ATE46332T1 (de) 1989-09-15
JPS61277671A (ja) 1986-12-08
ES555375A0 (es) 1987-11-01
ES557391A0 (es) 1988-02-16
KR860008984A (ko) 1986-12-19
PT82650A (en) 1986-06-01
HUT44767A (en) 1988-04-28
HU199845B (en) 1990-03-28
FI862251L (fi) 1986-11-30
AU5801286A (en) 1987-01-08
DD264213A5 (de) 1989-01-25
PL266365A1 (en) 1988-03-03
EP0203791B1 (en) 1989-09-13
PT82650B (pt) 1988-11-30
ZA863934B (en) 1988-01-27
DD264214A5 (de) 1989-01-25
HU196060B (en) 1988-09-28
PL147399B1 (en) 1989-05-31
FI862251A7 (fi) 1986-11-30
FI862251A0 (fi) 1986-05-28
PL147397B1 (en) 1989-05-31
EG17859A (en) 1991-11-30
KR890001548B1 (en) 1989-05-08
DE3665584D1 (de) 1989-10-19
IL78954A (en) 1989-09-28
IL78954A0 (en) 1986-09-30
US4575507A (en) 1986-03-11
GR861388B (en) 1986-09-17
DD251972A5 (de) 1987-12-02
DK248886A (da) 1986-11-30
PL266364A1 (en) 1988-03-03
NO862123L (no) 1986-12-01
PL146020B1 (en) 1988-12-31
PL147398B1 (en) 1989-05-31
PL266363A1 (en) 1988-03-03
DD264215A5 (de) 1989-01-25
HUT49882A (en) 1989-11-28
PL266366A1 (en) 1988-03-03
HU893127D0 (en) 1990-01-28

Similar Documents

Publication Publication Date Title
ES8703846A1 (es) Un procedimiento para preparar derivados de dihidropiridazi-nona
ES8604226A1 (es) Procedimiento para preparar (2-oxo-1, 2, 3, 5-tetrahidroimidazo (2, 1-b) quinazolinil) oxialquilamidas
ES8200374A1 (es) Un procedimiento para la manufactura continua de una hidro- xialquilcelulosa soluble en agua
ES8603866A1 (es) Procedimiento para la preparacion de nuevos compuestos fluo-roalcoxilicos
ES8104189A1 (es) Un procedimiento para la preparacion de derivados de feneta-nolamina
ES8303383A1 (es) Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol
ES8703405A1 (es) Un procedimiento para la preparacion de derivados de acetanilida
ES8306751A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES8801284A1 (es) Procedimiento para preparar nuevos compuestos de benzotiofeno y benzofurano
KR850000400A (ko) 피리딘 유도체
ES8403476A1 (es) Un procedimiento para la preparacion de 1-(3-halo-2-piridinil) piperazinas.
ES8801682A1 (es) Un procedimiento para la preparacion de nuevos compuestos poliprenilicos
ES8403112A1 (es) Un procedimiento para la preparacion de un derivado del pirbuterol.
JPS5756453A (en) Preparation of dialkali salt of dimercaptomaleonitrile
JPS5572134A (en) 4-allyloxy-3,5-disubstituted phenylacetaldehyde
ES8602607A1 (es) Un procedimiento para preparar sales de compuestos de fenantreno-metanol
JPS57165357A (en) Novel optically active azidocarboxylic acid or ester thereof and its preparation
JPS5427532A (en) Preparation of optical active 2-(substituted phenyl)-3-methyl-butyric acid chloride
ES8602619A1 (es) Un procedimiento para la preparacion de amidas del acido propionico.
ES8606838A1 (es) Procedimiento para preparar 9-antriloxiaminoalcanos
AU6560280A (en) (n-thenyl-2-methyl) amino-2-imidazoline
JPS5517335A (en) 5-fluoro-6-hydroxy-6-carboxy-5,6-dihydro-uracil and its preparation
ES8307203A1 (es) "un procedimiento para la fabricacion de una difenilamina".
JPS5321129A (en) Purification of brominated diphenyl ether
ES2011986A6 (es) Procedimiento para preparar derivados de ergolina.